Literature DB >> 19909666

Transcranial magnetic stimulation in the treatment of psychiatric disorders.

Deborah R Kim1, Angeliki Pesiridou, John P O'Reardon.   

Abstract

Transcranial magnetic stimulation (TMS) is an emerging novel treatment modality for psychiatric disorders, particularly major depression. A device for delivery of TMS was approved by the US Food and Drug Administration for treatment of major depressive disorder in adults. TMS is being studied for a variety of psychiatric disorders, including obsessive-compulsive disorder, post-traumatic stress disorder, and auditory hallucinations in schizophrenia. In this article, we describe TMS and its neurobiologic basis, as well as the efficacy and safety data of TMS with regard to a range of psychiatric disorders.

Entities:  

Mesh:

Year:  2009        PMID: 19909666     DOI: 10.1007/s11920-009-0068-z

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  48 in total

1.  A safety screening questionnaire for transcranial magnetic stimulation.

Authors:  J C Keel; M J Smith; E M Wassermann
Journal:  Clin Neurophysiol       Date:  2001-04       Impact factor: 3.708

2.  Transcranial magnetic stimulation in patients with bipolar depression: a double blind, controlled study.

Authors:  O T Dolberg; P N Dannon; S Schreiber; L Grunhaus
Journal:  Bipolar Disord       Date:  2002       Impact factor: 6.744

3.  No evidence of hearing loss in humans due to transcranial magnetic stimulation.

Authors:  A Pascual-Leone; L G Cohen; L I Shotland; N Dang; A Pikus; E M Wassermann; J P Brasil-Neto; J Valls-Solé; M Hallett
Journal:  Neurology       Date:  1992-03       Impact factor: 9.910

4.  Transcranial magnetic stimulation of deep brain regions: evidence for efficacy of the H-coil.

Authors:  Abraham Zangen; Yiftach Roth; Bernhard Voller; Mark Hallett
Journal:  Clin Neurophysiol       Date:  2004-12-16       Impact factor: 3.708

Review 5.  Factors modifying the efficacy of transcranial magnetic stimulation in the treatment of depression: a review.

Authors:  Lucie L Herrmann; Klaus P Ebmeier
Journal:  J Clin Psychiatry       Date:  2006-12       Impact factor: 4.384

6.  Can left prefrontal rTMS be used as a maintenance treatment for bipolar depression?

Authors:  Xingbao Li; Ziad Nahas; Berry Anderson; F Andrew Kozel; Mark S George
Journal:  Depress Anxiety       Date:  2004       Impact factor: 6.505

Review 7.  A review of repetitive transcranial magnetic stimulation use in the treatment of schizophrenia.

Authors:  Paul B Fitzgerald; Z Jeff Daskalakis
Journal:  Can J Psychiatry       Date:  2008-09       Impact factor: 4.356

8.  Acute mood and thyroid stimulating hormone effects of transcranial magnetic stimulation in major depression.

Authors:  M P Szuba; J P O'Reardon; A S Rai; J Snyder-Kastenberg; J D Amsterdam; D R Gettes; E Wassermann; D L Evans
Journal:  Biol Psychiatry       Date:  2001-07-01       Impact factor: 13.382

9.  Magnitude of placebo response and drug-placebo differences across psychiatric disorders.

Authors:  Arif Khan; Russell L Kolts; Mark H Rapaport; K Ranga Rama Krishnan; Amy E Brodhead; Walter A Browns
Journal:  Psychol Med       Date:  2005-05       Impact factor: 7.723

10.  Unexpected reduction in migraine and psychogenic headaches following rTMS treatment for major depression: a report of two cases.

Authors:  John P O'Reardon; Jeisson F Fontecha; Mario A Cristancho; Suzanne Newman
Journal:  CNS Spectr       Date:  2007-12       Impact factor: 3.790

View more
  17 in total

1.  Reversal of stress-induced dendritic atrophy in the prefrontal cortex by intracranial self-stimulation.

Authors:  K Ramkumar; B N Srikumar; D Venkatasubramanian; R Siva; B S Shankaranarayana Rao; T R Raju
Journal:  J Neural Transm (Vienna)       Date:  2011-12-14       Impact factor: 3.575

2.  Model-driven therapeutic treatment of neurological disorders: reshaping brain rhythms with neuromodulation.

Authors:  Julien Modolo; Alexandre Legros; Alex W Thomas; Anne Beuter
Journal:  Interface Focus       Date:  2010-11-17       Impact factor: 3.906

Review 3.  Use of transcranial magnetic stimulation in autism spectrum disorders.

Authors:  Lindsay M Oberman; Alexander Rotenberg; Alvaro Pascual-Leone
Journal:  J Autism Dev Disord       Date:  2015-02

Review 4.  Rethinking the thinking cap: ethics of neural enhancement using noninvasive brain stimulation.

Authors:  Roy Hamilton; Samuel Messing; Anjan Chatterjee
Journal:  Neurology       Date:  2011-01-11       Impact factor: 9.910

5.  Use of transcranial magnetic stimulation in bipolar disorder.

Authors:  Smita Agarkar; Nahla Mahgoub; Robert C Young
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2011       Impact factor: 2.198

Review 6.  Major depressive disorder: new clinical, neurobiological, and treatment perspectives.

Authors:  David J Kupfer; Ellen Frank; Mary L Phillips
Journal:  Lancet       Date:  2011-12-19       Impact factor: 79.321

7.  Examining cortical dynamics and connectivity with simultaneous single-pulse transcranial magnetic stimulation and fast optical imaging.

Authors:  Nathan A Parks; Edward L Maclin; Kathy A Low; Diane M Beck; Monica Fabiani; Gabriele Gratton
Journal:  Neuroimage       Date:  2011-09-08       Impact factor: 6.556

8.  Enhancing plasticity through repeated rTMS sessions: the benefits of a night of sleep.

Authors:  Daniel A Cohen; Catarina Freitas; Jose Maria Tormos; Lindsay Oberman; Mark Eldaief; Alvaro Pascual-Leone
Journal:  Clin Neurophysiol       Date:  2010-06-11       Impact factor: 3.708

9.  Effects of rTMS on Hippocampal Endocannabinoids and Depressive-like Behaviors in Adolescent Rats.

Authors:  Guoxiang Fang; Ying Wang
Journal:  Neurochem Res       Date:  2018-07-09       Impact factor: 3.996

Review 10.  Repetitive transcranial magnetic stimulation for clinical applications in neurological and psychiatric disorders: an overview.

Authors:  Sergio Machado; Oscar Arias-Carrión; Flávia Paes; Renata Teles Vieira; Leonardo Caixeta; Felipe Novaes; Tamires Marinho; Leonardo Ferreira Almada; Adriana Cardoso Silva; Antonio Egidio Nardi
Journal:  Eurasian J Med       Date:  2013-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.